Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate
Holmium Laser Ablation of the Prostate (HoLAP) Versus KTP Laser Vaporization of the Prostate: A Randomized Comparison Study
Sponsor: Indiana Kidney Stone Institute
Terminated
Poor enrollment
This observational or N/A phase trial investigates Benign Prostatic Hyperplasia and is currently terminated or withdrawn. Indiana Kidney Stone Institute leads this study, which shows 8 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Jan 2026 — Present [monthly]
Terminated
-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Nov 2022 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Nov 2022 [monthly]
Terminated
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Terminated NA
First recorded
May 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Indiana Kidney Stone Institute
- Lumenis Be Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .